Publications

Found 171 results
Filters: Author is Muyldermans, Serge  [Clear All Filters]
2009
Muyldermans, S., T. Nath Baral, C. V Retamozzo, P. De Baetselier, E. De Genst, J. Kinne, H. Leonhardt, S. Magez, V. K. Nguyen, H. Revets, et al., "Camelid immunoglobulins and nanobody technology.", Vet Immunol Immunopathol, vol. 128, issue 1-3, pp. 178-83, 2009 Mar 15.
Conrath, K., A. S. Pereira, C. E. Martins, C. G. Timóteo, P. Tavares, S. Spinelli, J. Kinne, C. Flaudrops, C. Cambillau, S. Muyldermans, et al., "Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.", Protein Sci, vol. 18, issue 3, pp. 619-28, 2009 Mar.
Vincke, C., R. Loris, D. Saerens, S. Martinez-Rodriguez, S. Muyldermans, and K. Conrath, "General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.", J Biol Chem, vol. 284, issue 5, pp. 3273-84, 2009 Jan 30.
Ben Abderrazek, R., I. Hmila, C. Vincke, Z. Benlasfar, M. Pellis, H. Dabbek, D. Saerens, M. El Ayeb, S. Muyldermans, and B. Bouhaouala-Zahar, "Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom.", Biochem J, vol. 424, issue 2, pp. 263-72, 2009 Dec 1.
Deckers, N., D. Saerens, K. Kanobana, K. Conrath, B. Victor, U. Wernery, J. Vercruysse, S. Muyldermans, and P. Dorny, "Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis.", Int J Parasitol, vol. 39, issue 5, pp. 625-33, 2009 Apr.
Butler, J. E., K. M. Lager, I. Splichal, D. Francis, I. Kacskovics, M. Sinkora, N. Wertz, J. Sun, Y. Zhao, W. R. Brown, et al., "The piglet as a model for B cell and immune system development.", Vet Immunol Immunopathol, vol. 128, issue 1-3, pp. 147-70, 2009 Mar 15.
2008
Saerens, D., G. Hassanzade Ghassabeh, and S. Muyldermans, "Antibody technology in proteomics.", Brief Funct Genomic Proteomic, vol. 7, issue 4, pp. 275-82, 2008 Jul.
Saerens, D., K. Conrath, J. Govaert, and S. Muyldermans, "Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.", J Mol Biol, vol. 377, issue 2, pp. 478-88, 2008 Mar 21.
Chan, P-H., E. Pardon, L. Menzer, E. De Genst, J. R. Kumita, J. Christodoulou, D. Saerens, A. Brans, F. Bouillenne, D. B. Archer, et al., "Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.", Biochemistry, vol. 47, issue 42, pp. 11041-54, 2008 Oct 21.
Saerens, D., B. Stijlemans, T. Nath Baral, G. Thanh Nguy Thi, U. Wernery, S. Magez, P. De Baetselier, S. Muyldermans, and K. Conrath, "Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.", J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
Saerens, D., G. Hassanzade Ghassabeh, and S. Muyldermans, "Single-domain antibodies as building blocks for novel therapeutics.", Curr Opin Pharmacol, vol. 8, issue 5, pp. 600-8, 2008 Oct.
Rothbauer, U., K. Zolghadr, S. Muyldermans, A. Schepers, C. M Cardoso, and H. Leonhardt, "A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins.", Mol Cell Proteomics, vol. 7, issue 2, pp. 282-9, 2008 Feb.
Hmila, I., B. Abderrazek R, D. Saerens, Z. Benlasfar, K. Conrath, M. El Ayeb, S. Muyldermans, and B. Bouhaouala-Zahar, "VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.", Mol Immunol, vol. 45, issue 14, pp. 3847-56, 2008 Aug.
2006
De Genst, E., D. Saerens, S. Muyldermans, and K. Conrath, "Antibody repertoire development in camelids.", Dev Comp Immunol, vol. 30, issue 1-2, pp. 187-98, 2006.
Kacskovics, I., B. Mayer, Z. Kis, L. V. Frenyó, Y. Zhao, S. Muyldermans, and L. Hammarström, "Cloning and characterization of the dromedary (Camelus dromedarius) neonatal Fc receptor (drFcRn).", Dev Comp Immunol, vol. 30, issue 12, pp. 1203-15, 2006.
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].", Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.", Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
Brüggemann, M., J. A. Smith, M. J. Osborn, D. Corcos, X. Zou, V. Khong Nguyen, and S. Muyldermans, "Heavy-chain-only antibody expression and B-cell development in the mouse.", Crit Rev Immunol, vol. 26, issue 5, pp. 377-90, 2006.
De Genst, E., K. Silence, K. Decanniere, K. Conrath, R. Loris, J. Kinne, S. Muyldermans, and L. Wyns, "Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.", Proc Natl Acad Sci U S A, vol. 103, issue 12, pp. 4586-91, 2006 Mar 21.
Marquardt, A., S. Muyldermans, and M. Przybylski, "A synthetic camel anti-lysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry.", Chemistry, vol. 12, issue 7, pp. 1915-23, 2006 Feb 20.
Rothbauer, U., K. Zolghadr, S. Tillib, D. Nowak, L. Schermelleh, A. Gahl, N. Backmann, K. Conrath, S. Muyldermans, C. M Cardoso, et al., "Targeting and tracing antigens in live cells with fluorescent nanobodies.", Nat Methods, vol. 3, issue 11, pp. 887-9, 2006 Nov.

Pages